Status:
RECRUITING
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Wuxi Hisky Medical Technology Co Ltd
Conditions:
Nonalcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis
Eligibility:
All Genders
Brief Summary
Identifying patients at risk of NAFLD(Nonalcoholic fatty liver disease), especially severe disease with NASH(nonalcoholic steatohepatitis) and fibrosis, is critical. Prevalence of NAFLD in PLWH(People...
Detailed Description
Chronic liver disease is now a leading cause of non-AIDS-related death, representing 13% of all deaths in this patient population. While coinfection with viral hepatitis is the primary cause of liver ...
Eligibility Criteria
Inclusion
- Newly treated or treated AIDS patients;
- Regular follow-up visits to the hospital, medication compliance is good;
- Patients or their family members were willing to participate in the study by understanding the study plan and providing written informed consent.
Exclusion
- Unable to complete the position requirements of ultrasonic examination (lying flat) due to mobility difficulties;
- Patients have poor compliance and cannot follow up regularly or take medicine on time;
- Patients or family members cannot understand the conditions and objectives of the study;
- Other conditions considered unsuitable for inclusion by the investigator.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05330923
Start Date
May 1 2022
End Date
June 1 2029
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese Academy of Medical Sciences Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100020